๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zibo
Clinical trial register · China

Clinical Trials in Zibo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Zibo

17 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
QT Interval/Corrected QT Interval ๏ผˆQT/QTc๏ผ‰ Clinical Study to Evaluate the Cardiac Safety of TQ05105 Tablets in Healthy Participants
NCT07708272Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
60
Zibo
2026-07-30
Not yet open
Effects of Exercise Sequence and Meal Sequence on Weight Management Among Children and Adolescents With Overweight or Obesity: The STEP Trial
NCT07712068Obesity & Overweight, Insulin Resistance, Inflamation
Peking University
Not applicable
480
Wuhu, Zhengzhou, Shenyang, Zibo, Shanghai, Hangzhou, Jinhua, Beijing
2026-07
Recruiting
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
NCT07745244type1diabetes, CGM, T1D
SiBionics, Co, Ltd
Not applicable
36
Zibo
2026-06-01
Recruiting
Evaluating Midline Catheters in Clinical Practice
NCT07677696Safety and Effectiveness of Midline Catheters, Vascular Access Devices
Shandong Branden Med.Device Co.,Ltd
Observational
10,000
Zibo
2026-05-01
Not yet open
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
NCT07485920Limited-stage Small Cell Lung Cancer (LS-SCLC)
The Affiliated Hospital of Qingdao University
Phase 4
20
Qingdao, Weihai, Yantai, Zibo
2026-05-01
Active, closed
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233Acute Ischemic Stroke
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645Ischemic Stroke
Capital Medical University
Phase 3
348
Suzhou, Anyang, Nanyang, Xinxiang, Zhoukou, Linyi, Zibo, Xianyang
2026-04-22
Recruiting
A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
NCT07594847Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
72
Zibo
2026-03-07
Recruiting
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
NCT07436949Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
DrugBBT002
Bambusa Therapeutics
Phase 1/2
64
Beijing, Guangzhou, Changsha, Nanjing, Jinan, Qingdao, Yantai, Zibo
2026-03-02
Recruiting
A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants
NCT07162116Acute Myeloid Leukemia With FLT3/ITD Mutation
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Phase 1
45
Zibo
2025-07-06
Recruiting
An Efficacy and Safety Study of Akkermansia Muciniphila AKM Lab-01 in Hypercholesterolaemia
NCT06974266Hypercholesterolaemia
Moon (Guangzhou) Biotechnology Co., Ltd.
Not applicable
60
Zibo
2025-06-25
Recruiting
Clinical Study on the Treatment of Type 1 Diabetes With CNK-UT009 Cell Injection
NCT07051564Type 1 Diabetes (T1D)
Zibo Central Hospital
Not applicable
12
Zibo
2025-05-06
Recruiting
Study of LM-299 in Subjects Advanced Malignant Tumors
NCT06650566Malignant Tumors
LaNova Medicines Limited
Phase 1/2
108
Xinxiang, Liaocheng, Zibo, Shanghai
2024-10-09
Not yet open
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
NCT06606483Obesity, Overweight and Obesity
MindRank AI Ltd
Phase 2
300
Hefei, Xuancheng, Zibo, Beijing, Haikou, Shijiazhuang, Harbin, Luoyang
2024-09-23
Recruiting
Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer๏ผšA Prospective, Single-Arm, Phase II Study
NCT07085182NSCLC, Tislelizumab, Chemotherapy, Hypofractionated Radiotherapy
Zibo Municipal Hospital
Phase 2
20
Zibo
2024-01-13
Recruiting
Post-market European & Asian Registry to Evaluate the Minosโ„ข Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm Using Endovascular Stent Graft
Shanghai MicroPort Endovascular MedTech๏ผˆGroup๏ผ‰Co., Ltd
Observational
200
Lanzhou, Meizhou, Shenzhen, Changsha, Xiangtan, Yueyang, Zibo, Binhai
2023-03-05
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/zibo

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies with a site in Zibo.

How many clinical trials are recruiting in Zibo?

12 of the 17 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zibo), 17 studies
PhaseStudiesRecruitingShare
Not applicable4323.5%
Phase 14223.5%
Phase 23217.6%
Observational2211.8%
Phase 1/22211.8%
Phase 3115.9%
Phase 4105.9%

Most active sponsors

Lead sponsors with the most studies (Zibo)
Lead sponsorStudiesRecruiting
Capital Medical University21
Zibo Municipal Hospital22
Bambusa Therapeutics11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.11
LaNova Medicines Limited11
MindRank AI Ltd10
Moon (Guangzhou) Biotechnology Co., Ltd.11
Peking University10
Shandong Branden Med.Device Co.,Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.